No matching items found
SHOWING 4 Results
Amid a torrent of negative and worrisome news related to COVID-19 pandemic globally, Moderna Inc’s claim that its experimental COVID-19 vaccine, the first to be tested in the United States, has produced protective antibodies in a small group of healthy volunteers injects hope and some relief.
The Ministry of Health and Prevention has started testing antibodies to the COVID-19 in three affiliated laboratories run by Pure Health under a partnership agreement between the two parties.
Antibodies have become a familiar word in the pandemic era, perhaps suggesting they’re the best hope for keeping the deadly coronavirus at bay. But when crucial vaccine data was released this week, the spotlight panned to an unsung immune player: T cells.
"Liberia, Sierra Leone, Zambia, Zimbabwe, Cameroon, Nigeria, Morocco are the first set of countries that committed to it," said John Nkengasong, head of the Africa Centres for Disease Control and Prevention, based in Addis Ababa.